It’s the most wonderful time of the year! Some people have Christmas in July. Or the Fourth of July. I have nine days of fandom…
Myeloma
Dosing has begun in a Phase 3 clinical trial testing whether the antibody therapy Gamunex-C (immune globulin injection [human], 10% caprylate/chromatography purified) can help prevent…
The U.S. Food and Drug Administration (FDA) has set a date for next year by which it will decide whether or not to approve a…
Some days, I watch my mother try to stand, and my breath catches. The doctors have warned us about bone weakness — how…
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…
Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…
Recent Posts
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML
- When the caregiver role starts to feel like a second skin